BPC-157: What Does Current Research Say?
An overview of the scientific research into BPC-157, a synthetic pentadecapeptide investigated for tissue-repairing properties.
BPC-157 (Body Protection Compound-157) is a synthetic peptide consisting of 15 amino acids, derived from a protective protein naturally found in human gastric juice. In scientific literature it is also referred to as bepecin or PL 14736.
What is being researched?
In preclinical models โ primarily in rats and mice โ BPC-157 is investigated for its potential role in:
- Tissue regeneration: Studies suggest BPC-157 influences the expression of growth factor receptors such as VEGFR2, which is involved in angiogenesis (the formation of new blood vessels).
- Gastrointestinal protection: Due to its origin from gastric fluid, it is studied in the context of gastrointestinal tract protection.
- Tendon and ligament system: Experimental models have investigated whether BPC-157 can influence the healing of tendons and ligaments.
Scientific context
It is important to emphasise that BPC-157 is not approved for human use by the EMA or any other medicines authority. It is exclusively in the preclinical research phase. Nova Labs sells BPC-157 as a research compound, intended solely for use in a controlled laboratory environment.
Scientific publications are available via PubMed and Google Scholar under the search terms "BPC-157" or "gastric pentadecapeptide".
Combination research
BPC-157 is regularly combined with TB-500 (Thymosin Beta-4 fragment) in experimental setups. This combination is known in the research community as the "Wolverine Stack" and is investigated for potentially synergistic effects.
*This article is informational and scientific in nature only. Nova Labs does not sell medicines and does not provide medical advice.*
Nova Labs sells exclusively research peptides for use in controlled laboratory environments. Our products are not intended for human use. View our range โ